Organoclick Valuation
| ORGC Stock | SEK 2.65 0.04 1.53% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Organoclick AB holds a recent Real Value of kr2.35 per share. The prevailing price of the company is kr2.65. Our model determines the value of Organoclick AB from analyzing the company fundamentals such as Operating Margin of (0.27) %, return on equity of -0.32, and Shares Outstanding of 97.95 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Organoclick's price fluctuation is unstable at this time. Calculation of the real value of Organoclick AB is based on 3 months time horizon. Increasing Organoclick's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Organoclick's intrinsic value may or may not be the same as its current market price of 2.65, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.65 | Real 2.35 | Hype 2.65 | Naive 2.56 |
The intrinsic value of Organoclick's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Organoclick's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Organoclick AB helps investors to forecast how Organoclick stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Organoclick more accurately as focusing exclusively on Organoclick's fundamentals will not take into account other important factors: Organoclick Total Value Analysis
Organoclick AB is now anticipated to have takeover price of 352.06 M with market capitalization of 365.11 M, debt of 24.85 M, and cash on hands of 34.25 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Organoclick fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
352.06 M | 365.11 M | 24.85 M | 34.25 M |
Organoclick Investor Information
About 35.0% of the company outstanding shares are owned by corporate insiders. The book value of Organoclick was now reported as 0.81. The company recorded a loss per share of 0.33. Organoclick AB had not issued any dividends in recent years. Based on the analysis of Organoclick's profitability, liquidity, and operating efficiency, Organoclick AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Organoclick Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Organoclick has an asset utilization ratio of 58.42 percent. This implies that the Company is making kr0.58 for each dollar of assets. An increasing asset utilization means that Organoclick AB is more efficient with each dollar of assets it utilizes for everyday operations.Organoclick Ownership Allocation
Organoclick owns a total of 97.95 Million outstanding shares. Organoclick has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Organoclick Profitability Analysis
The company reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M.About Organoclick Valuation
The stock valuation mechanism determines Organoclick's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Organoclick AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Organoclick. We calculate exposure to Organoclick's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Organoclick's related companies.OrganoClick AB develops, produces, and markets functional materials in Sweden. OrganoClick AB was founded in 2006 and is headquartered in Tby, Sweden. OrganoClick operates under Research And Specialist Materials classification in Sweden and is traded on Stockholm Stock Exchange.
8 Steps to conduct Organoclick's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Organoclick's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Organoclick's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Organoclick's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Organoclick's revenue streams: Identify Organoclick's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Organoclick's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Organoclick's growth potential: Evaluate Organoclick's management, business model, and growth potential.
- Determine Organoclick's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Organoclick's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.